Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society.

Name: Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society.
Author: Abe, Yoshiaki

Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society. — المؤلف: Abe, Yoshiaki — Oncotarget Jan 2019

المؤلف: Abe, Yoshiaki
النشر: Oncotarget Jan 2019
الوصف: 595-605 p.